• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[恶病质和非恶病质肺癌患者的血清瘦素水平]

[Leptin serum levels in cachectic and non-cachectic lung cancer patients].

作者信息

Weryńska Bozena, Kosacka Monika, Gołecki Marcin, Jankowska Renata

出版信息

Pneumonol Alergol Pol. 2009;77(6):500-6.

PMID:20013699
Abstract

INTRODUCTION

Leptin, protein taking part in body mass regulation, might play a role in cancer cachexia development. The aim of the study was to measure leptin serum levels in cachectic, non-cachectic lung cancer patients, healthy controls and to correlate leptin concentration with nutritional status markers.

MATERIAL AND METHODS

40 lung cancer patients were enrolled into the study: 20 with cachexia, 20 without cachexia, and 10 healthy controls. Leptin serum concentration, body mass, BMI, arm circumference and skin triceps fold thickness were measured in each subject.

RESULTS

Serum leptin level in cachectic cancer patients was significantly lower than in non-cachectic and healthy controls. Leptin concentration correlated with body mass, arm circumference and skin triceps fold thickness.

CONCLUSIONS

Cachectic lung cancer patients have significantly lower serum leptin concentrations than non-cachectic patients and healthy controls which may suggest, that leptin does not play an important role in cancer cachexia development. Leptin levels positively correlate with good nutritional status markers. Non-cachectic lung cancer patients have similar leptin serum levels as healthy controls.

摘要

引言

瘦素是一种参与体重调节的蛋白质,可能在癌症恶病质的发展中起作用。本研究的目的是测量恶病质肺癌患者、非恶病质肺癌患者及健康对照者的血清瘦素水平,并将瘦素浓度与营养状况指标进行关联。

材料与方法

40例肺癌患者纳入本研究,其中20例患有恶病质,20例无恶病质,另有10例健康对照者。测量了每位受试者的血清瘦素浓度、体重、体重指数、上臂围和肱三头肌皮褶厚度。

结果

恶病质癌症患者的血清瘦素水平显著低于非恶病质患者和健康对照者。瘦素浓度与体重、上臂围和肱三头肌皮褶厚度相关。

结论

恶病质肺癌患者的血清瘦素浓度显著低于非恶病质患者和健康对照者,这可能表明瘦素在癌症恶病质的发展中不起重要作用。瘦素水平与良好的营养状况指标呈正相关。非恶病质肺癌患者的血清瘦素水平与健康对照者相似。

相似文献

1
[Leptin serum levels in cachectic and non-cachectic lung cancer patients].[恶病质和非恶病质肺癌患者的血清瘦素水平]
Pneumonol Alergol Pol. 2009;77(6):500-6.
2
[Effect of serum leptin on nutritional status of patients with cancer].[血清瘦素对癌症患者营养状况的影响]
Wei Sheng Yan Jiu. 2002 Apr;31(2):100-2.
3
Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients.乳腺癌和结肠癌患者癌症恶病质中的脂联素、胃饥饿素和瘦素
Cancer. 2006 Feb 15;106(4):966-73. doi: 10.1002/cncr.21690.
4
[Preliminary investigation of effect of serum leptin on nutritional state of COPD patients].[血清瘦素对慢性阻塞性肺疾病患者营养状况影响的初步研究]
Zhonghua Jie He He Hu Xi Za Zhi. 2000 May;23(5):292-5.
5
Estimation of serum leptin in oral squamous cell carcinoma.血清瘦素在口腔鳞状细胞癌中的评估。
J Oral Pathol Med. 2010 Jan;39(1):69-73. doi: 10.1111/j.1600-0714.2009.00808.x. Epub 2009 Oct 9.
6
Adiponectin is increased in cardiac cachexia irrespective of body mass index.无论体重指数如何,心脏恶病质患者体内的脂联素水平都会升高。
Eur J Heart Fail. 2009 Jun;11(6):567-72. doi: 10.1093/eurjhf/hfp046. Epub 2009 Apr 9.
7
Transdermal fentanyl in cachectic cancer patients.恶病质癌症患者的透皮芬太尼
Pain. 2009 Jul;144(1-2):218-22. doi: 10.1016/j.pain.2009.04.012. Epub 2009 May 12.
8
Increased plasma ghrelin level in lung cancer cachexia.肺癌恶病质中血浆胃饥饿素水平升高。
Clin Cancer Res. 2003 Feb;9(2):774-8.
9
Adipokines in patients with cancer anorexia and cachexia.癌症恶病质患者的脂肪细胞因子。
J Investig Med. 2010 Mar;58(3):554-9. doi: 10.231/JIM.0b013e3181cf91ca.
10
Nutrition, inflammation, and leptin levels in aging and frailty.衰老与衰弱过程中的营养、炎症及瘦素水平
J Am Geriatr Soc. 2008 Feb;56(2):279-84. doi: 10.1111/j.1532-5415.2007.01548.x. Epub 2007 Dec 27.

引用本文的文献

1
Metabolic Reprogramming in Adipose Tissue During Cancer Cachexia.癌症恶病质期间脂肪组织中的代谢重编程
Front Oncol. 2022 May 12;12:848394. doi: 10.3389/fonc.2022.848394. eCollection 2022.
2
Evaluation of Serum Resistin, Visfatin, and Chemerin Levels in Patients with Lung Cancer and Chronic Obstructive Pulmonary Disease.肺癌和慢性阻塞性肺疾病患者血清抵抗素、内脏脂肪素和chemerin水平的评估
Turk Thorac J. 2020 May;21(3):169-173. doi: 10.5152/TurkThoracJ.2019.19001.
3
A systematic review of the overlap of fluid biomarkers in delirium and advanced cancer-related syndromes.
一项关于谵妄和晚期癌症相关综合征中液体生物标志物重叠的系统评价。
BMC Psychiatry. 2020 Apr 22;20(1):182. doi: 10.1186/s12888-020-02584-2.
4
Serum and tissue leptin in lung cancer: A meta-analysis.肺癌中的血清和组织瘦素:一项荟萃分析。
Oncotarget. 2017 Mar 21;8(12):19699-19711. doi: 10.18632/oncotarget.14963.
5
Potential Biomarkers of Fat Loss as a Feature of Cancer Cachexia.作为癌症恶病质特征的脂肪减少的潜在生物标志物。
Mediators Inflamm. 2015;2015:820934. doi: 10.1155/2015/820934. Epub 2015 Oct 5.
6
Emerging markers of cachexia predict survival in cancer patients.恶病质的新兴标志物可预测癌症患者的生存率。
BMC Cancer. 2014 Nov 16;14:828. doi: 10.1186/1471-2407-14-828.
7
[Advances of the relationship between leptin system and non-small cell lung cancer].[瘦素系统与非小细胞肺癌关系的研究进展]
Zhongguo Fei Ai Za Zhi. 2014 Apr;17(4):347-50. doi: 10.3779/j.issn.1009-3419.2014.04.10.
8
Leptin in anorexia and cachexia syndrome.厌食症和恶病质综合征中的瘦素
Int J Pept. 2012;2012:287457. doi: 10.1155/2012/287457. Epub 2012 Feb 8.
9
Adipokines and systemic inflammation in weight-losing lung cancer patients.减肥肺癌患者的脂肪因子和全身炎症。
Lung. 2012 Jun;190(3):327-32. doi: 10.1007/s00408-011-9364-6. Epub 2012 Jan 14.